Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2010
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777049 Serotonin receptor antagonists
08/17/2010US7777033 Durable antimicrobial activity and heat resistance, non-eluting to prevent toxicity, and do not adversly effect properties of molded products; use in packaging, appliances, cosmetics, and medical equipment; e.g. polymerizable derivatives of grepafloxacin
08/17/2010US7776910 Piperazinyl-substituted quinolinone compounds ;to treat nervous system diseases, neurodegenerative diseases; gastrointestinal tract disorders; cognition enhancers; 3-[4-(3-Ethylsulfanyl-benzenesulfonyl)-2-methoxy-phenyl]-pyrrolidine and 5-(3-Ethylsulfanyl-benzenesulfonyl)-2-pyrrolidin-3-yl-phenol
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776864 Fused bicyclic pyrimidines
08/17/2010US7776855 Antimicrobial oxazolidinone prodrugs
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2461963C Cyclic amine compounds
08/17/2010CA2397734C Water soluble prodrugs of azole compounds
08/17/2010CA2377236C Pyrazole derivative, production process thereof, and pest control agent containing the same as active ingredient
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/12/2010WO2010090290A1 Aminopyrazine derivative and medicine
08/12/2010WO2010090009A1 Indoline derivatives
08/12/2010WO2010089292A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010WO2010042758A3 Oxazole-pyridazine-oxazole alpha-helix mimetic
08/12/2010WO2010036640A3 Compounds for the treatment of inflammatory disorders
08/12/2010US20100204465 Refined routes to chlorin building blocks
08/12/2010US20100204371 Sterically hindered amines and use thereof as polymer stabilizers
08/12/2010US20100204260 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204237 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204230 Piperazine derivatives for treatment of ad and related conditions
08/12/2010US20100204229 Fungicide heterocyclyl-pyrimidinyl-amino derivatives
08/12/2010US20100204228 Aryl Sulfonamides Useful for Modulation of the Progesterone Receptor
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204209 CCR2 Receptor Antagonists and Uses Thereof
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204207 Compounds and Methods for Treating Dyslipidemia
08/12/2010US20100204200 Inhibitors of cathepsin s
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010US20100200508 Perchlorate Ion Trapping Agent
08/12/2010US20100199443 Yello anionic disazo dyes
08/12/2010CA2751695A1 Aminopyrazine derivatives and medicines
08/12/2010CA2751536A1 Indoline derivatives
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2748862A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2215083A2 Process for pure irbesartan
08/11/2010EP2215082A1 Phthalazine and pyrido ý3,4-d¨pyridaz ine compounds as h1 receptor antagonists
08/11/2010EP2215080A1 Diazepane compounds which modulate the cb2 receptor
08/11/2010EP2215074A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
08/11/2010EP2215067A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
08/11/2010EP2215066A1 Amide derivatives as sirtuin modulators
08/11/2010EP2215058A1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
08/11/2010EP2214667A2 Small molecule inhibitors of parp activity
08/11/2010EP2214487A1 Novel seh inhibitors and their use
08/11/2010EP2214486A1 Heteroaryl compounds and uses thereof
08/11/2010EP2099763B1 2-aminoquinolines as 5-ht(5a) receptor antagonists
08/11/2010EP2049529B1 Substituted diazepan orexin receptor antagonists
08/11/2010EP1756076B1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
08/11/2010CN1997649B Inhibitors of histone deacetylase
08/11/2010CN101801961A Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
08/11/2010CN101801960A prodrugs to thyroid hormone analogs
08/11/2010CN101801959A Aminopyrimidines useful as kinase inhibitors
08/11/2010CN101801955A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/11/2010CN101801952A N-heterocyclic biaryl carboxamides as ccr receptor antagonists
08/11/2010CN101801935A uracil or thymine derivative for treating hepatitis c
08/11/2010CN101801934A 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/11/2010CN101801925A antiviral compounds
08/11/2010CN101801384A methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
08/11/2010CN101801383A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/11/2010CN101798301A Pyrrolidyl pyrimidine methanesulfonamide derivatives and preparation method thereof
08/11/2010CN101798300A N-phenylindole methyl substituted bis-benzimidazole derivative and application thereof in reducing blood pressure and the like
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101798287A [(4-methyl-2-propyl-N-methoxyl-substituted benzene alkyl-1H-benzimidazole-6-formamide)-1-yl] methyldiphenyl compound and preparation method thereof
08/11/2010CN101318933B Isoquinolinium compounds with antithrombotic activity, preparation method and application thereof
08/10/2010US7772485 Polymers with low band gaps and high charge mobility
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
08/10/2010US7772270 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
08/10/2010US7772254 Pyridylene compounds used as analgesics and for inhibiting Vanilloid Receptor 1 and metabotropic glutamate receptor 1 function in a cells
08/10/2010US7772253 Amide derivatives as somatostatin receptor 5 antagonists
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772235 4-(5-{(1R)-1-[5-(3-Chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,- 4-triazol-3-yl)-1-methylpyridin-2(1H)-one; transient lower esophageal sphincter relaxations; gastroesophageal reflux disease; pain; anxiety; irritable bowel syndrome; metabotropic glutamate receptor inhibitors; peripherally acting
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772221 2-ethyl-hexanoic acid ((1S,4R,5S,8S,14R)-5-benzyl-4-hydroxy-18-methoxy-7-oxo-13-oxa-2,6-diaza-tricyclo[12.6.1.015,20]henicosa-10, 15(20),16,18-tetraen-8-yl)-methyl-amide; Alzheimer's Disease, Down's Syndrome; inhibitors of beta-secretase processing of amyloid precursor proteins
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2334399C Uracil compounds and use thereof
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010088518A2 Heterocyclic modulators of gpr119 for treatment of disease
08/05/2010WO2010088406A1 Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/05/2010WO2010088050A2 Bicyclic pyrazolo-heterocycles
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086366A1 4-aryl-butane-1,3-diamides
08/05/2010WO2010042867A3 Activators of human pyruvate kinase
08/05/2010WO2010031056A3 Methods and compositions for modulating ire1, src, and abl activity
08/05/2010WO2009156837A3 Amorphous form of a 3-pyrrole substituted 2-indolinone malate salt